Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Correlation Between Imatinib Trough Concentration and Efficacy in Advanced GIST Patients with Different Genotypes
ClinicalTrials.gov study NCT06628739. IPD Sharing: NO. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
ClinicalTrials.gov study NCT00042952. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen
ClinicalTrials.gov study NCT00426179. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib
ClinicalTrials.gov study NCT01343173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Trial of Imatinib Mesylate in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
ClinicalTrials.gov study NCT00171938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107
ClinicalTrials.gov study NCT01368523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT01503502. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
ClinicalTrials.gov study NCT00323791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT00324077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of REduction And DIscontinuation Treatment of TKI (Imatinib, Nilotinib, Dasatinib and Bosutinib)
ClinicalTrials.gov study NCT04578847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vactosertib and Imatinib Combination in Patients with Advanced Desmoid Tumor/aggressive Fibromatosis (DT/AF)
ClinicalTrials.gov study NCT06219733. IPD Sharing: NO. Countries: 1. Publications: 0.
Drug-drug Interaction Study With Metformin and Imatinib
ClinicalTrials.gov study NCT01404715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00301093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Jejunoileal vs Gastric GIST in the Era of Imatinib.
ClinicalTrials.gov study NCT03923400. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Myelofibrosis
ClinicalTrials.gov study NCT00039416. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years
ClinicalTrials.gov study NCT00219752. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)
ClinicalTrials.gov study NCT01221376. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
ClinicalTrials.gov study NCT01073436. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Population Pharmacokinetics of Imatinib in CML Patients in Iran
ClinicalTrials.gov study NCT02146846. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00049192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.